Glassman Wealth Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-130
| Closed | -$114K | – | 1445 |
|
|
2023
Q4 | $114K | Buy |
130
+3
| +2% | +$2.64K | 0.02% | 273 |
|
|
2023
Q3 | $105K | Sell |
127
-1
| -0.8% | -$823 | 0.02% | 268 |
|
|
2023
Q2 | $92K | Buy |
128
+4
| +3% | +$2.87K | 0.01% | 277 |
|
|
2023
Q1 | $102K | Buy |
124
+7
| +6% | +$5.75K | 0.02% | 264 |
|
|
2022
Q4 | $84.4K | Buy |
117
+8
| +7% | +$5.77K | 0.02% | 298 |
|
|
2022
Q3 | $75K | Buy |
109
+9
| +9% | +$6.19K | 0.02% | 300 |
|
|
2022
Q2 | $59K | Sell |
100
-2
| -2% | -$1.18K | 0.01% | 354 |
|
|
2022
Q1 | $71K | Buy |
102
+25
| +32% | +$17.4K | 0.01% | 325 |
|
|
2021
Q4 | $49K | Buy |
77
+33
| +75% | +$21K | 0.01% | 378 |
|
|
2021
Q3 | $27K | Buy |
44
+8
| +22% | +$4.91K | 0.01% | 506 |
|
|
2021
Q2 | $20K | Buy |
36
+9
| +33% | +$5K | ﹤0.01% | 574 |
|
|
2021
Q1 | $13K | Hold |
27
| – | – | ﹤0.01% | 652 |
|
|
2020
Q4 | $13K | Hold |
27
| – | – | ﹤0.01% | 652 |
|
|
2020
Q3 | $15K | Buy |
27
+3
| +13% | +$1.67K | ﹤0.01% | 517 |
|
|
2020
Q2 | $15K | Sell |
24
-2
| -8% | -$1.25K | ﹤0.01% | 427 |
|
|
2020
Q1 | $13K | Buy |
26
+16
| +160% | +$8K | 0.01% | 401 |
|
|
2019
Q4 | $4K | Sell |
10
-8
| -44% | -$3.2K | ﹤0.01% | 631 |
|
|
2019
Q3 | $5K | Buy |
18
+6
| +50% | +$1.67K | ﹤0.01% | 540 |
|
|
2019
Q2 | $4K | Sell |
12
-15
| -56% | -$5K | ﹤0.01% | 600 |
|
|
2019
Q1 | $11K | Buy |
27
+20
| +286% | +$8.15K | ﹤0.01% | 440 |
|
|
2018
Q4 | $3K | Hold |
7
| – | – | ﹤0.01% | 504 |
|
|
2018
Q3 | $3K | Hold |
7
| – | – | ﹤0.01% | 552 |
|
|
2018
Q2 | $2K | Buy |
7
+1
| +17% | +$286 | ﹤0.01% | 580 |
|
|
2018
Q1 | $2K | Buy |
6
+1
| +20% | +$333 | ﹤0.01% | 552 |
|
|
2017
Q4 | $2K | Sell |
5
-3
| -38% | -$1.2K | ﹤0.01% | 509 |
|
|
2017
Q3 | $4K | Buy |
8
+3
| +60% | +$1.5K | ﹤0.01% | 374 |
|
|
2017
Q2 | $2K | Hold |
5
| – | – | ﹤0.01% | 423 |
|
|
2017
Q1 | $2K | Sell |
5
-1
| -17% | -$400 | ﹤0.01% | 455 |
|
|
2016
Q4 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 516 |
|